Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy

Impairment of cardiac function in ischemic cardiomyopathy has been postulated to be due to the decrease in blood flow and increase in collagen synthesis. Therefore, an approach to alter them directly by means of a growth factor may open up a new therapeutic concept in ischemic cardiomyopathy. From t...

Full description

Saved in:
Bibliographic Details
Published inGene therapy Vol. 13; no. 16; pp. 1206 - 1213
Main Authors AZUMA, J, TANIYAMA, Y, TAKEYA, Y, IEKUSHI, K, AOKI, M, DOSAKA, N, MATSUMOTO, K, NAKAMURA, T, OGIHARA, T, MORISHITA, R
Format Journal Article
LanguageEnglish
Published Basingstoke Nature Publishing Group 01.08.2006
Subjects
Online AccessGet full text

Cover

Loading…